Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

828
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
828
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-Tuberculosis Lung Disease: The Role of Surgical Management.

Thoracic surgery clinics·2026
Same author

Surgery for Active and Drug-Resistant Tuberculosis.

Thoracic surgery clinics·2026
Same author

Update on Tuberculosis Treatment and Drug Regimens.

Cold Spring Harbor perspectives in medicine·2026
Same author

World TB Day 2026: Scientific innovation across the tuberculosis continuum must now translate into global impact.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Do we need to revise the dose of isoniazid for the treatment of tuberculosis in children?

The European respiratory journal·2026
Same author

Feasibility and efficacy of a population-based pulmonary rehabilitation for post-tuberculosis lung disease in Bangladesh.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Related Experiment Video

Updated: Apr 30, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.2K

Facing multi-drug resistant tuberculosis.

Giovanni Sotgiu1, Giovanni Battista Migliori2

  • 1Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy.

Pulmonary Pharmacology & Therapeutics
|May 6, 2014
PubMed
Summary

Multi-drug resistant tuberculosis (MDR-TB) presents treatment challenges due to drug resistance. New drugs like bedaquiline and delamanid show promise, alongside off-label options, to improve patient outcomes.

Keywords:
EliminationMDR-TBMycobacterium tuberculosisSecond-line drugsStop TB strategyXDR-TB

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.1K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

18.4K

Related Experiment Videos

Last Updated: Apr 30, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.2K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.1K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

18.4K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Multi-drug resistant tuberculosis (MDR-TB) stems from Mycobacterium tuberculosis strains resistant to key drugs like isoniazid and rifampicin.
  • Existing second- and third-line treatments for MDR-TB exhibit limited efficacy, safety, and tolerability.
  • High MDR-TB incidence, particularly in Eastern Europe and Central Asia, is linked to prior anti-tuberculosis drug exposure.

Purpose of the Study:

  • To review the current landscape of multi-drug resistant tuberculosis (MDR-TB) treatment.
  • To highlight challenges in MDR-TB management, including drug resistance and treatment adherence.
  • To explore emerging therapeutic options and the need for further research and development.

Main Methods:

  • Literature review of existing studies on MDR-TB treatments.
  • Analysis of factors contributing to MDR-TB emergence and spread.
  • Evaluation of promising new drugs and off-label antibiotic regimens.

Main Results:

  • MDR-TB treatment faces significant hurdles with current regimens.
  • Bedaquiline and delamanid demonstrate potential in combating drug resistance.
  • Off-label use of linezolid, meropenem/clavulanate, and cotrimoxazole shows favorable profiles.

Conclusions:

  • Urgent need for novel diagnostic, therapeutic, and preventive strategies for MDR-TB.
  • Expert consultation is vital for optimizing individualized MDR-TB therapy.
  • Continued research is essential to address the growing threat of drug-resistant tuberculosis.